Renejix – Small Molecule CDMO (USA)
Comparing the dissolution rates and pellet fine structure of branded Zovirax® with three similar acyclovir generic products marketed across the world, all containing the same API itraconazole. Raman spectroscopy revealed recrystallizing API slowed the dissolution rate.
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by…
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
It is typical to encounter a restricted number of APIs during the initial stages of drug development. This limitation hinders the swift…
A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in…